
Fresenius Medical Care fell 13.9% from $23.75 to $20.44, behind the S&P 500's +3.2%. Its worst day was May 5 (−10.9%), and its low came Nov 19 at $20.13.
Nov 24, 2025 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Fresenius Medical Care shares fell 6.5%, while the S&P 500 fell 0.5%.
−6.5% · S&P 500 −0.5%
EPS of $0.84 beat the $0.67 estimate on $5.9B revenue (est. $5.9B); FY revenue guidance of $23.8B against the $22.6B consensus.
Story events cover the past 12 months · Times ET
−7.8% · S&P 500 +0.7%
EPS of $0.53 missed the $0.59 estimate on $5.4B revenue (est. $5.7B); FY revenue guidance of $23.8B against the $22.9B consensus.
−10.9%, the year's worst day · S&P 500 +0.8%
Fresenius Medical Care shares rose 4.9%, while the S&P 500 rose 0.4%.
+4.9% · S&P 500 +0.4%
EPS of $0.66 beat the $0.64 estimate on $5.7B revenue (est. $5.7B); FY revenue guidance of $23.8B against the $22.9B consensus.
−1.6% · S&P 500 +1.4%
Fresenius Medical Care shares fell 7.7%, while the S&P 500 fell 0.2%.
−7.7% · S&P 500 −0.2%
EPS of $0.64 missed the $0.71 estimate on $5.7B revenue (est. $5.9B); FY revenue guidance of $23.8B against the $22.5B consensus.
−3.9% · S&P 500 +0.3%
Where it ended: a close of $20.44 on Nov 20, 2026. Up next: Q4 2026 earnings on Feb 23, 2027 (EPS est. $0.87).
Replay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for FMS and SPY from Benzinga historical bars. Not investment advice.